Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins

British Journal of Dermatology

Volumn 160, Issue 2, 2009, Pages 259-265

  Lopez, S ^a   Torres, M J ^a   Rodriguez Pena R ^a   Blanca Lopez, N ^b   Fernandez, T D ^a   Antunez, C ^a   Canto, G ^b   De Luque, V ^c   Mayorga, C ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Allergy; Delayed reactions; Dendritic cells; Heparins; Lymphocytes

Indexed keywords

ATERINA; BEMIPARIN; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; FRAXIPARINA; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REFLUDIN; SULODEXIDE; TINZAPARIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE TRANSFORMATION TEST; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVOCATION TEST; SKIN TEST; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CROSS REACTIONS; DENDRITIC CELLS; DRUG ADMINISTRATION SCHEDULE; DRUG HYPERSENSITIVITY; FEMALE; HEPARIN; HUMANS; HYPERSENSITIVITY, DELAYED; LYMPHOCYTE ACTIVATION; MIDDLE AGED; SKIN TESTS;

EID: 58349088710     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08875.x     Document Type: Article

References (25)

1. Hirsh J, Warkentin TE, Shaughnessy SG et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001 119 : S64 94.
2. Hirsh J, O'Donnell M, Weitz JI. New anticoagulants. Blood 2005 105 : 453 63.
3. Bircher AJ, Harr T, Hohenstein L, Tsakiris DA. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options. Allergy 2006 61 : 432 40.
4. Grassegger A, Fritsch P, Reider N. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study. Dermatol Surg 2001 27 : 47 52.
5. Poza-Guedes P, Gonzalez-Perez R, Canto G. Different patterns of cross-reactivity in non-immediate hypersensitivity to heparins: from localized to systemic reactions. Contact Dermatitis 2002 47 : 244 5.
6. Utikal J, Peitsch WK, Booken D et al. Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy. Thromb Haemost 2005 94 : 895 6.
7. Greinacher A, Lubenow N, Eichler P. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia. Circulation 2003 108 : 2062 5.
8. Molinari JF, Campo C, Shakir S, Ahmed T. Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin. Am J Respir Crit Care Med 1998 157 : 887 93.
9. Ali S, Hardy LA, Kirby JA. Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans? Transplantation 2003 75 : 1773 82.
10. Douglas MS, Ali S, Rix DA et al. Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation. Immunology 1997 92 : 512 18.
11. Lever R, Hoult JR, Page CP. The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro. Br J Pharmacol 2000 129 : 533 40.
12. Ranjbaran H, Wang Y, Manes TD et al. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells. Circulation 2006 114 : 1293 300.
13. Bottio T, Pittarello G, Bonato R et al. Life-threatening anaphylactic shock caused by porcine heparin intravenous infusion during mitral valve repair. J Thorac Cardiovasc Surg 2003 126 : 1194 5.
14. Jappe U. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update. Blood Coagul Fibrinolysis 2006 17 : 605 13.
15. Bircher AJ. Diagnostic tests for delayed type-hypersensitivity reactions to heparins and safety of intravenous heparin. Am J Contact Dermat 1994 5 : 56 7.
16. Ji SL, Cui HF, Shi F et al. Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes. World J Gastroenterol 2004 10 : 3490 4.
17. Torres MJ, Mayorga C, Fernández TD et al. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006 19 : 119 30.
18. Rodríguez-Pena R, Lopez S, Mayorga C et al. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol 2006 118 : 949 56.
19. Ludwig RJ, Schindewolf M, Utikal J et al. Management of cutaneous type IV hypersensitivity reactions induced by heparin. Thromb Haemost 2006 96 : 611 17.
20. Bircher AJ, Itin PH, Tsakiris DA, Surber C. Delayed hypersensitivity to one low-molecular-weight heparin with tolerance of other low-molecular-weight heparins. Br J Dermatol 1995 132 : 461 3.
21. Ludwig RJ, Schindewolf M, Alban S et al. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. Thromb Haemost 2005 94 : 1265 9.
22. Pawelec G, Wagner W, Adibzadeh M, Engel A. T cell immunosenescence in vitro and in vivo. Exp Gerontol 1999 34 : 419 29.
23. Grims RH, Weger W, Reiter H et al. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Br J Dermatol 2007 157 : 514 17.
24. Luque I, Leyva L, Torres MJ et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001 56 : 611 18.
25. Gaigl Z, Pfeuffer P, Raith P et al. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study. Br J Haematol 2005 128 : 389 92.